Allucent

Allucent is a global, full-service contract research organization (CRO) that partners with small and mid-sized biopharmaceutical companies to advance therapies from early development through clinical trials and post-approval. Drawing on more than 30 years of regulatory, therapeutic, and operational experience, the company combines specialized expertise with a flexible, collaborative approach tailored to each client’s needs.

Its services span drug development strategy, regulatory consulting and submissions, CMC and preclinical support, clinical pharmacology, and clinical trial design and management. Allucent also provides study start-up and site feasibility, patient recruitment and retention, data management, biostatistics, statistical programming, medical monitoring, and clinical trial safety services. For approved products, it supports post-marketing studies and pharmacovigilance.

The company’s therapeutic experience includes oncology and hematology, neuroscience, infectious diseases and vaccines, immunology, cardiometabolic disease, rare diseases, pediatrics, and cell and gene therapy. With a global network spanning more than 60 countries, Allucent helps biopharma teams navigate development challenges, build evidence, and pursue regulatory approval for new treatments.